Podcasts about Hepatitis C

Why can someone accused of a serious crime be released on bail — and why might the detectives investigating them sometimes be pleased when that happens?Former Scottish detectives Tom Wood and Simon McLean take an inside look at bail and remand: what bail actually means, how the system has changed during their careers, and the factors courts consider when deciding whether an accused person should remain at liberty or be held in custody pending trial.They discuss the days when bail could literally mean putting up money for someone's release, the continuing use of bail bonds in the United States, and the underlying principle in Scots law that an accused person has not yet been convicted and should normally remain at liberty unless there is sufficient reason to keep them in custody.Tom and Simon examine the practical reasons bail may be opposed, including:the seriousness of the alleged offence;the risk of absconding;further offending;interference with witnesses;destruction or concealment of evidence;and obstruction of justice.Tom also reveals a less obvious reality from major investigations: detectives could sometimes be quite pleased when a person facing a serious charge was granted bail. Keeping someone in custody starts strict legal timetables and can put enormous pressure on investigators trying to assemble a complex case.The conversation also explores how Scottish bail law developed through precedent and stated cases, changes to the modern bail test, the use of remand, and the police practice of releasing accused people on undertakings to appear at court.Simon and Tom also refer to the recent Simon Levy case while discussing the risks associated with offending while on bail.Later, the conversation moves to policing and drugs, as Tom discusses news he had read about advances in hepatitis C treatment. That prompts both detectives to recall the very real dangers faced by officers searching people who used injected drugs — including uncapped needles, needle-stick injuries and the routine question: “Do you have any sharps? Do you have any spikes?”It's an aspect of criminal justice that everyone has heard of, but one that is often very different from the version portrayed on television.Real cases. Real detectives. Real talk.Suggested Chapters00:00 — Cold open: why detectives might actually want bail00:52 — What bail really means01:28 — When bail meant money03:08 — Liberty before trial and the presumption of bail04:17 — When bail can be opposed04:34 — Simon Levy and offending while on bail05:04 — Why accused people are remanded06:10 — Why bail can help a murder investigation06:54 — Common law, precedent and stated cases10:20 — Modern bail rules and reducing remand11:55 — What police put before prosecutors12:40 — Undertakings and release from custody13:55 — Lord Wheatley and the war on drugs14:54 — Hepatitis C and the risks faced by drug-squad officers18:11 — ClosingAbout Crime Time Inc.Season 5 of Crime Time Inc. broadens its reach across two sides of the Atlantic.This season features cases from Scotland and across the wider UK — rooted in real investigative experience — alongside deep dives into some of the most infamous murder cases in American history.Hosted by former detectives Simon and Tom, with experience in both the UK and the United States, including time working alongside the FBI, the show strips away sensationalism to explain how crime and justice really work.Two crime worlds. One podcast.New episodes released regularly throughout the season.Our Website: https://crimetimeinc.com/If you like this show please leave a review. It really helps us.Please help us improve our Podcast by completing this survey.http://bit.ly/crimetimeinc-survey Hosted on Acast. See acast.com/privacy for more information.

This week we talk about the liver, viral infections, and the NHS.We also discuss blood scandals, needle usage, and Nobel Prizes.Recommended Book: A World Appears by Michael PollanTranscriptThe term “hepatitis” refers to the inflammation of the liver, which can result from all kinds of things, including environmental toxins, the consumption of alcohol, or autoimmune diseases. It can also result from viral infections, and the most prominent liver-inflaming viruses are called viral hepatitis.There are five types of viral hepatitis, A, B, C, D, and E, and each of these viruses are distinct, not part of the same viral family, they're just similarly named because they impact the same organ.Hepatitis A and E are primarily spread through contaminated food and water, and generally resolve on their own, untreated, and cause relatively mild symptoms. Hepatitis B and C are spread through blood and other bodily fluids, and can linger in a host's body for decades before even showing symptoms. Hepatitis D is a parasite of Hepatitis B, and thus only infects people who carry Hepatitis B.Now again, these are all different conditions that just happen to inflame the liver, so impact and treatment also vary quite a lot. As I mentioned, A and E generally present with mild symptoms and tend to go away on their own, while B and C can stick around a long time. There's a vaccine for B, but no cure; you can treat it, but that treatment involves suppressing it, and keeping it suppressed, forever. Hep C, in contrast, is curable, and has been since 2014 using what are called direct-acting antiviral pills, but these pills, which are taken for 8 to 12 weeks, are expensive—ranging from $22-95k without insurance, though that price is often reduced substantially for those with insurance, down to as low as $5. This category of drug coverage is often rejected by insurance companies, though, in part because they're so expensive, that expense the result of little competition in this space; few companies make this type of drug, so those that do can charge more or less whatever they like.Some people with Hepatitis C clear it on their own; about 30% of people who contract it, in fact, clear it within a few months, medication-free. Which is good, because our understanding of this virus is relatively new. Up until 1989, Hep C didn't even have its own name: it was established as its own thing, not Hep A and not Hep B, back in the 1970s, and doctors knew that something that wasn't those two viruses, that was being spread by transfusions, was causing hepatitis symptoms, but they didn't know any real specifics, so they just called it “non-A, non-B hepatitis,” and that name stuck for more than a decade.In 1989 the virus was cloned using molecular techniques (as opposed to simply growing the virus, which wasn't proving fruitful in trying to isolate and identify the thing), and the folks who managed that cloning, and the person who later proved that the genome they cloned, alone, caused the disease, received a Nobel Prize in Medicine for their efforts in 2020.By 1991, antibody tests were available for Hep C, and many countries began screening donated blood for this virus, to ensure it wasn't working its way into their blood supply.And one instance of that screening process, or I suppose, an event that led up to mass screening, and the consequences that followed, are what I'd like to talk about today. The UK's efforts in trying to eliminate Hep C, and England's recently announced near-success in that pursuit.—Hepatitis C is an RNA virus with high genetic variability that makes developing a reliable vaccine difficult. And though somewhere between a quarter and a third of all cases clear on their own, those that don't clear on their own become chronic, lying in wait for twenty to thirty years, slowly accumulating fibrosis—thick scar tissue in the liver—which eventually results in cirrhosis, which means a liver that's so heavily scarred that the organ is no longer fully functional and the damage is permanent. From there, infected people often experience liver failure or hepatocellular (huh-pah-toe) carcinoma, liver cancer.So this virus is a sleeper, and unless it's caught by accident somewhere along the way, it slowly causes damage over time until the damage is too severe to reverse. About 80% of people who have it don't know they have it, and in some parts of the world medical injections are the most common transmitter, but in higher-income areas, it's usually transmitted by injectable drugs.Pre-2014 treatments for Hep C were pretty horrible, involving a combination antiviral therapy called pegylated interferon plus ribavirin that was injected weekly for six months to a year, and this was terribly tolerated by pretty much everyone, causing anemia, depression, and flu-like symptoms for the duration. It also only cured about 50% of people who received the full treatment, and a lot of people had to stop because it caused such ridiculous side effects.Another antiviral called Sofosbuvir (so-FAS-buh-vir), which kept Hep C from replicating in its host, hit the market in late-2013, and that led to a series of direct-acting antivirals that reduced the treatment period dramatically, allowing most people, 95%, to cure their Hep C entirely by taking generally well-tolerated pills for 8 to 12 weeks.These pills were staggeringly expensive from the get-go, with an entire treatment course initially costing about $84,000, or $1,000 a pill. This led to rationing, and saving these pills for the worst-impacted people who already had severe liver damage. There were also pretty stringent requirements attached to their distribution, including that people who received them could no longer drink alcohol, because it was considered a waste to give these crazy expensive, liver-saving drugs to people who would just go and hurt their liver more, anyway.In the UK, the demand for this treatment type was different than in most other countries, in large part because of something that happened back in the 1970s and 80s.The UK's publicly funded healthcare system, the NHS, was in the midst of a shortage of clotting factor, which are plasma proteins and ions that help blood clot and which are used for medical purposes. So they imported a bunch of plasma products from the US, and those products were sourced from the blood of paid donors—and that donor pool included prisoners and people who used injectable drugs. Just one Hep C contaminated blood donation could contaminate an entire batch of blood, and remember, they only started screening the blood supply for Hep C in 1991, and they didn't start treating their blood supply for Hep C until a little before that, 1985, so this was well before they had any idea what was in those blood products they were importing and administering.Consequently, between 1970 and the early 1990s, more than 30,000 NHS patients received transfusions or other blood product treatments contaminated with Hep B, Hep C, or HIV, and about a tenth of those people, around 3,000 patients, have since died of those conditions.The UK government leaned on denial and a refusal to look into the details of this for years, but in 2017 it announced an independent public inquiry into the matter, and in May of 2024, that inquiry concluded that this whole scandal was avoidable, that patients were knowingly exposed to “unacceptable risks,” and that there was a big cover up by government officials, doctors, and other people working with the NHS.As of mid-2026, only a little over 3,200 people of the more than 18,500 who registered claims, demanding compensation from the government because they were impacted by this scandal, have been paid out. The expected total expense for the UK government is on the order of 12.8 billion pounds, but a lot of people who are probably due a payout, and who are in poor and deteriorating health as a consequence of all this, don't yet have a sense of when they'll receive their payment.Back in 2016, before all that came to a head, the UK set itself an aggressive goal: to eliminate Hep C by the WHO's 2030 target, or before. It then ran a competitive tender for antivirals, inviting medical suppliers to submit competing bids, resulting in the largest single medicine procurement program in the NHS' history. The pharmaceutical companies that won their bids were also obliged, as part of the agreement, to help fund efforts to identify undiagnosed but infected patients, in addition to supplying antiviral pills, and this combination of investment and application led to the deployment of new tests and scanning machines, free postal test kits, the hiring of specialists, and services that focused on prisons and drug users.The impact of all this has been significant: a more than 61% decline in infections from 2015 to 2024, nearly half of all drug users with Hep C had cleared the virus in that time, and deaths from Hep C are down 36% over the past decade.The WHO treatment-coverage target—the percentage of people who are diagnosed getting treatment—was 80%, and England has hit 81.5%, which was recently announced to much fanfare. It hasn't yet hit the diagnosis target, however, which is to diagnose 90% of people who are estimated to have Hep C; they've hit 84.6%, which is still quite a lot of progress, even if they're not yet where they'd like to be. That's all based on models, of course, as are the assumed number of infections among people who use injectable drugs, which is also a spot where England is currently flagging; there's no centralized system in England to monitor needle and syringe provisions, and reinfection rates are around 8.8 per 100 person-years among people who had injected within three years of receiving treatment, and that rate is even higher for people who have ever been to prison, around 9.4 per 100.What that means in practice is that the English government overall has done a pretty astounding and effective job at negotiating their relationships with pharma companies and getting detection on track at that scale, but on more ground-level issues that are, interestingly, a lot cheaper to implement, but at times more politically complicated because of public sentiment about drug use and drug users, they're doing a lot less well—and important to note here is that these outcomes vary a bit across the four programs being run across the UK. Scotland and Wales are doing relatively better and worse in some regards compared to England, for instance.Also worth noting here that while England is broadly doing a great job with Hep C diagnosis and treatment, they aren't the first to achieve those WHO-set goals: Egypt reached Gold tier status according to the WHO's Hep C guidelines in October of 2023, at that point having diagnosed 87% of people who have the virus, and treating 93% of those who were diagnosed. They managed to cut incidence of the virus by 97% in just 8 years, leaning on a system of high-yield testing—they tested more than 60 million people during those 8 years—alongside a production scheme that included local manufacturing of antivirals, making them more available and affordable.All of which are generally good signs about where Hep C testing and treatment is going, at least in these regions. And it paints a optimistic picture for other countries that might want to replicate some of what's working within their own borders.Show Noteshttps://www.bbc.com/news/articles/c75gk620r22ohttps://en.wikipedia.org/wiki/Infected_blood_scandal_in_the_United_Kingdomhttps://en.wikipedia.org/wiki/Hepatitis_Chttps://en.wikipedia.org/wiki/Viral_hepatitishttps://en.wikipedia.org/wiki/Hepatitis_Bhttps://www.healthline.com/health/hepatitis-c/treatment-costshttps://www.who.int/news-room/fact-sheets/detail/hepatitis-chttps://publichealthscotland.scot/publications/surveillance-of-hepatitis-c-in-scotland/surveillance-of-hepatitis-c-in-scotland-progress-on-elimination-of-hepatitis-c-as-a-major-public-health-concern-2025-update/https://www.emro.who.int/media/news/egypt-becomes-the-first-country-to-achieve-who-validation-on-the-path-to-elimination-of-hepatitis-c.htmlhttps://www.gov.uk/government/publications/hepatitis-c-in-england-and-the-uk/hepatitis-c-in-england-2025https://www.england.nhs.uk/2026/08/100000-people-receive-treatment-to-cure-deadly-hep-c-virus-on-nhs-in-just-ten-years/https://www.hepctrust.org.uk/blog/2019/04/hepatitis-c-trust-welcomes-elimination-deal-hepatitis-c-and-calls-government-backed/https://commonslibrary.parliament.uk/research-briefings/cbp-10099/https://www.who.int/teams/global-hiv-hepatitis-and-stis-programmes/hepatitis/reports/global-hepatitis-report-2026 This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit letsknowthings.substack.com/subscribe

Coming up, Australian researchers have found a new way to help prevent malaria. How have they done it? Also, the UK is "leading the world" in efforts to eliminate hepatitis C, a designer vest that could protect our astronauts from space radiation, and how a new aerogel-based toothpaste can tackle tooth sensitivity. Like this podcast? Please help us by supporting the Naked Scientists

Trump calls on Iran to pay compensation for the deaths and injuries of Americans in conflicts allegedly linked to Tehran, The Washington Post reports that Trump was snuck out of Turkey in a catering container, Russia frees an ailing U.S. Marine after four years in detention, Syria sentences al-Assad to death in absentia, Republican senators release a batch of Fauci's COVID-19 text messages, Turkey approves a conditional pardon bill for thousands of PKK members, Lebanon Indicts ex-central bank chief for Salameh for alleged embezzlement, the U.S. Justice Department sends polling monitors to in Minnesota's primaries, a U.S. court rejects social media companies' bids to block thousands of youth addiction suits, and the U.K. says it's close to eliminating Hepatitis C. Sources: Verity.News

https://rumble.com/user/TheCultureWarshttps://x.com/NewsK365https://buymeacoffee.com/courtpresshttps://www.youtube.com/@NewsK365Email: newsk365@protonmail.com

https://rumble.com/user/TheCultureWarshttps://x.com/NewsK365https://buymeacoffee.com/courtpresshttps://www.youtube.com/@NewsK365Email: newsk365@protonmail.com

https://rumble.com/user/TheCultureWarshttps://x.com/NewsK365https://buymeacoffee.com/courtpresshttps://www.youtube.com/@NewsK365Email: newsk365@protonmail.com

https://rumble.com/user/TheCultureWarshttps://x.com/NewsK365https://buymeacoffee.com/courtpresshttps://www.youtube.com/@NewsK365Email: newsk365@protonmail.com

https://rumble.com/user/TheCultureWarshttps://x.com/NewsK365https://buymeacoffee.com/courtpresshttps://www.youtube.com/@NewsK365Email: newsk365@protonmail.com

Crece el río Lerma, habitantes piden auxilioAseguran 200 kilos de metanfetamina en Sonora Las autoridades no me intimidan: Evo Morales #grc

Today I'm chatting with Nurse Amber, a board-certified women's health nurse practitioner, to discuss sexual health and STIs. We cover the prevalence and stigma of herpes, common STIs like chlamydia and gonorrhea, testing frequency, and prevention methods including PrEP and DoxyPEP. Our conversation also addresses female health concerns such as UTIs, bacterial vaginosis, and pelvic floor health, as well as men's sexual health topics. Nurse Amber emphasizes open communication, regular testing, and finding a sex-positive healthcare provider.Understanding Herpes Transmission (00:02:11)Discussion on HSV-1 and HSV-2, how both can be transmitted genitally or orally, and why blood testing has limited utility.Most Common STIs (00:08:18)Chlamydia, gonorrhea, and trichomonas are identified as the most common STIs seen in clinical practice, with chlamydia being most frequent.Symptoms of Common STIs (00:08:50)A description of potential STI symptoms in people with vaginas and penises, noting that 50% of cases are asymptomatic.What is Trichomonas? (00:10:02)An explanation of trichomonas, a common parasitic STI that often causes no symptoms but can cause severe inflammation.Long-Term Risks of Untreated STIs (00:11:50)Untreated bacterial STIs can lead to serious complications like Pelvic Inflammatory Disease (PID), chronic pain, and impaired fertility.STI Incubation Periods (00:14:39)Genital STIs are detectable 1-2 weeks post-exposure, while blood-borne infections like HIV and syphilis can take 1-3 months.How to Disclose an STI to a Partner (00:15:53)Advice on having a direct conversation with partners about a positive STI test and the need for mutual treatment.STI Testing Frequency (00:17:19)Recommendations for testing frequency based on sexual activity, ranging from every 6-12 months to every 2-3 months for active individuals. PrEP and DoxyPEP Explained (00:21:49)An overview of PrEP for HIV prevention and DoxyPEP, a post-exposure prophylaxis to reduce the risk of bacterial STIs.Syphilis is Not Gone (00:26:47)Syphilis, known as "the great pretender," is still prevalent and can have sneaky symptoms, making regular screening important.The Current State of HIV (00:29:00)HIV is now a highly treatable chronic condition, and transmission rates are much lower than for other STIs like Hepatitis C.What to Ask For at the Gynecologist (00:31:59)Clarifying that a pelvic exam is not always a Pap smear and what specific STI tests patients should request.The Importance of Triple Testing (00:37:23)Why testing genital, oral, and rectal sites is crucial for a comprehensive screening, as infections can exist in one area.Myth-Busting: Partner Testing (00:42:04)Debunking the myth that if one partner tests negative, the other is also clear. Each person needs individual testing.Vaginal Health and Hygiene (00:44:01)Advice on maintaining vaginal health, emphasizing that vaginas are self-cleaning and harsh soaps or douching should be avoided.Squirting and Prolapse (00:50:31)Explaining that squirting is largely urine and discussing bladder prolapse, a common condition that can cause stress incontinence.Pelvic Floor Health (00:54:39)How to maintain pelvic floor health through exercises like Pilates and yoga, which can improve sex and prevent incontinence.Hormone Replacement Therapy (HRT) (00:58:16)A discussion on the benefits and considerations of HRT for perimenopausal symptoms, cautioning against unproven testing methods.When Men Should See a Doctor (01:02:54)An overview of symptoms like itching, discharge, pain, or sores that should prompt a person with a penis to seek medical care.Finding a Sex-Positive Provider (01:17:29)The importance of finding a healthcare provider you can be open with about your sexual health for accurate testing and treatment.Follow The Open Bedroom:https://www.instagram.com/theopenbedroompodcast/

Hepatitis zählt zu den gefährlichsten Infektionskrankheiten weltweit – und bleibt doch oft lange unentdeckt. Im Hörgang der MedUni Graz erklärt die Hepatologin Vanessa Stadlbauer-Köllner, warum insbesondere Hepatitis B und C noch immer ein großes Gesundheitsproblem darstellen. Viele Betroffene wissen nichts von ihrer Infektion, weil die Erkrankung oft jahrelang ohne klare Symptome verläuft. Dabei können die Folgen schwerwiegend sein: Leberzirrhose, Leberkrebs und andere Komplikationen. Die Expertin spricht über aktuelle Entwicklungen bei Prävention und Therapie, über wirksame Impfungen gegen Hepatitis A und B sowie über die nahezu vollständige Heilbarkeit von Hepatitis C. Zudem zeigt sie, warum flächendeckende Tests und bessere Gesundheitskommunikation entscheidend sind. Eine Folge über eine stille Krankheit, die jeden treffen kann – und über die Chancen, sie rechtzeitig zu erkennen und zu verhindern.

Q-Bank: https://www.patreon.com/highyieldfamilymedicineIntro (0:35),Liver Function Tests (1:42),Hepatitis A (4:33),Hepatitis B (6:02),Hepatitis C (8:44),MASLD (10:51),Alcoholic Liver Disease (12:11),Autoimmune Hepatitis (13:29),Acetaminophen Toxicity (14:53),Wilson Disease (15:55),Hemochromatosis (17:28),Cirrhosis (18:48),Ascites (20:59),Esophageal Varices (23:36),Hepatic Encephalopathy (24:54),Hepatorenal Syndrome (26:31),Hepatocellular Carcinoma Screening (27:52),Practice Questions (28:39)

The Addicted Mind Podcast: How a Little Becomes a Lot with Eric ZimmerIn this episode, Duane welcomes back Eric Zimmer, host of The One You Feed podcast, behavior coach, and author of the new book, How a Little Becomes a Lot: The Art of Small Changes for a More Meaningful Life.Eric shares his profound journey from being a homeless heroin addict facing 50 years in prison to building a deeply meaningful life in long-term recovery. Together, Duane and Eric break down why massive life transformations don't happen overnight, but are instead built on thousands of microscopic daily decisions. They explore how to navigate behavioral "choice points," overcome the trap of perfectionism, and beautifully balance the duality of acceptance and change.Key Takeaways from the EpisodeThe Fallacy of the "Big Moment": While "moments of clarity" are real and pivotal, they only matter if they are backed up by small, daily actions over time.Change is a Skill: Struggling to change a habit is not a character flaw or a sign of laziness; it is a skill set that must be practiced and learned.The Autopilot Pitfall: Many of our worst habits occur completely outside of our conscious awareness. Learning to slow down and introduce deliberation is key to making better choices.The 80% Rule: Except for active substance addiction, striving for 80% consistency in life (exercise, meditation, healthy eating) protects you from the self-sabotage of perfectionism.Puzzles Over Problems: Shifting your perspective from "I have a problem" to "I have a puzzle" opens the door to curiosity and solutions rather than shame.In-Depth Discussion TopicsAt 24 years old, Eric was a homeless heroin addict, weighing 100 pounds, jaundiced from Hepatitis C, and facing severe prison time. When he finally agreed to long-term treatment, it wasn't his first attempt. Eric explains how his previous "failures" to stay clean were actually an essential part of his learning process.Mastering "Choice Points"A choice point is that exact split-second where you either move toward your best self or fall back into old behaviors. Eric notes that relying purely on willpower at a choice point is a losing game. Instead, behavior change requires two distinct layers:Structural Elements: This includes your support system, clear protocols, accountability partners, and removing triggers from your environment.In-the-Moment Skills: This involves recognizing self-doubt, slowing down the urge, and learning how to "trick" yourself into taking action by shrinking the task (e.g., just putting on your running shoes to walk to the mailbox)."The music producer Quincy Jones has this line, and I love it. He says, 'I don't have problems, I have puzzles.' There's a shift in there that's really important, because a puzzle has a solution. It has an answer. We just haven't figured it out yet." — Eric ZimmerMoving Beyond the Self-Improvement ProjectThe episode wraps up with a deep dive into the final chapters of Eric's book, focusing on presence and radical acceptance. While it seems counterintuitive for a book about behavior change to end on "allowing everything to be exactly as it is," Eric explains that treating your life as a non-stop self-improvement project strips away contentment. True healing happens when we can skillfully change what we can, while holding space for our pain, low moods, and current realities without judgment.Framework: The 80% Rule vs. The Perfection MindsetThe Perfection MindsetThe 80% Consistency FrameworkViews every slip-up as a total failure.Views slip-ups as temporary data points and "puzzle pieces."Relies heavily on high motivation and intense willpower.Relies on structural support, habits, and reducing friction.Leads to burnout, self-sabotage, and quitting.Leads to long-term, sustainable lifestyle changes."If I can't do it perfectly, why bother?""If I can just hit 80% consistency over a year, I'm winning."Resources Mentioned in this EpisodeEric Zimmer's Website: oneyoufeed.net (Find his podcast, behavior coaching program, and new book)Eric's Book:How a Little Becomes a Lot: The Art of Small Changes for a More Meaningful Life – A Guide to Lasting Transformation Through Behavioral Science and WisdomThe Addicted Mind Website: theaddictedmind.comFollow and Review: We'd love it even more if you could drop a review or 5-star rating over on Apple Podcasts. Simply select “Ratings and Reviews” and “Write a Review” then a quick line with your favorite part of the episode. It only takes a second and it helps spread the word about the podcast.Supporting Resources:If you live in California and are looking for counseling or therapy please check out Novus Mindful Life Counseling and Recovery CenterNovusMindfulLife.comWe want to hear from you. Leave us a message or ask us a question: https://www.speakpipe.com/addictedmindDisclaimerSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

In Episode 136 of DC EKG, Joe Grogan hosts Tom Barker, a top drug-pricing attorney at Foley Hoag and former acting general counsel of Health and Human Services (HHS) under the Bush administration. Tom helped implement Medicare Part D and now advises drugmakers and policymakers on complex pricing issues. The episode traces 20 years of policy: what went right with Part D, what the Inflation Reduction Act (IRA) did, and what effective policy should look like.Tom explains that Part D's success rested on three pillars: private plans only, limited government control over benefit design, and a non-interference clause barring the government from intervening in negotiations among plans, pharmacies, and manufacturers. Competition worked and premiums stayed low, until the government asserted more control and weakened those pillars. The IRA, he argues, was a 16-year Democratic effort to repeal non-interference, creating price controls disguised as negotiations.The Trump administration has taken a different tack, focusing not on the IRA but on MFN and Globe Guard models pegged to other developed countries. Tom also breaks down the 340B program, now the country's second-largest expenditure program, and the fight between manufacturers and covered entities over contract pharmacies.His prescription is simple: let competition work. Speed FDA approval of generics and biosimilars, and trust the marketplace over price controls. He points to hepatitis C, where prices fell sharply once competition entered.In This ConversationThe three pillars that made Part D successful for 20 yearsHow non-interference kept government from setting drug pricesThe IRA as a 16-year Democratic push to repeal non-interferenceWhy Tom calls the IRA price controls disguised as negotiationsThe Trump administration's focus on MFN and Globe Guard pricing340B and the battle between manufacturers and covered entitiesThe Chevron repeal's impact on drug pricing lawHRSA's proposed rebate model and ongoing 340B litigationWhy effective policy means competition, not controlsTom's work helping North Korean defectors and refugeesKey Timestamps1:51 Tom's background at HHS and CMS2:30 The three pillars of Part D's success5:10 Why Democrats wanted to repeal non-interference5:55 Ted Kennedy's compromise and bipartisan votes11:38 The IRA as a 16-year repeal attempt12:03 What the IRA changed in Part D15:02 IRA negotiations vs. real negotiations16:25 How the excise tax makes it no real negotiation21:32 Trump's focus on MFN and Globe Guard25:37 340B's history back to 199128:45 340B as the second-biggest expenditure program29:30 Manufacturer vs. covered-entity acrimony33:18 The Chevron repeal's impact on pricing34:54 HRSA's rebate model, the next step on 340B35:40 The lawsuit over "patient" in 340B38:18 Tom's advice: let competition work39:30 Hepatitis C: competition drives prices down40:34 Competition for gene therapies and CRISPR41:36 Tom's work for North Korean defectors44:49 Sponsoring Free North Korea RadioMedicare Part D, drug pricing policy, Inflation Reduction Act, non-interference clause, 340B program, MFN pricing, Globe Guard pricing, pharmacy benefit managers, covered entities, contract pharmacies, biosimilars, generics, federal drug pricing, government price controls, Tom BarkerAbout the GuestTom Barker is a partner at Foley Hoag in Washington, DC, and one of the country's top drug pricing attorneys. He served as acting general counsel of HHS and chief legal officer at CMS under the Bush administration, where he helped implement Part D from its inception. He is now a go-to expert on drug pricing, and helps North Korean defectors navigate US immigration law.Podcast: DC EKG with Joe Grogan Episode: 136 Guest: Tom Barker Sponsor: Survivors for Solutions - https://survivorsforsolutions.org Executive Producer: John "CZ" Czwartacki, DC EKG Podcast Producer: Stay on Course Studios - https://www.stayoncourse.studio

This episode covers hepatitis C.Notes: https://zerotofinals.com/paediatrics/infectiousdisease/hepc/Questions: https://members.zerotofinals.com/Books: https://zerotofinals.com/books/The audio in the episode was expertly edited by Harry Watchman.

It's Monday, May 18. Here are today's top stories around Central Indiana. Want to go deeper on the stories you hear on WFYI News Now? Visit wfyi.org and follow us on social media to get local news every day. WFYI News Now is hosted by Barb Anguiano and produced by Zach Bundy. Subscribe wherever you get your podcasts.

New York State's Hepatitis C Dashboard shows that in 2023, 4,783 people were newly diagnosed with HCV in the state, an 8% decrease from 2022. Incidence also decreased, with the rate of new HCV infections dropping from 4.0 to 3.6 per 100,000 population among adult New Yorkers. Despite these gains, progress towards elimination has been stalled by reliance on a multi-step diagnostic algorithm to confirm viremia. In populations with the highest risk of infection – including people who inject drugs – testing and treatment are often inaccessible due to barriers along the care cascade. On June 27, 2024, the U.S. Food and Drug Administration authorized the first point-of-care (POC) HCV RNA test that can be performed where a person receives care, like an outpatient clinic or mobile unit. The availability of a POC HCV RNA testing, which can provide a qualitative results in 60 minutes, unlocks New York's ability to integrate a test-and-treat approach where a person can be tested for HCV, and if positive for HCV RNA, be linked to care and potentially receive treatment during the same health care visit. To achieve elimination goals, simplified care that engaged people who inject drugs is essential, and single encounter testing and treatment offers a new tool to significantly expand access, decrease time from diagnosis to treatment and increase the number of New Yorkers who are treated for HCV. Today's episode will focus on this new diagnostic tool and its potential impact on HCV elimination across New York. Related Content:  New York State Department of Health Clinical Guidelines Program, Hepatitis C Virus Screening, Testing, and Diagnosis in Adults (January 2023): https://www.hivguidelines.org/guideline/hcv-testing/?mycollection=hepatitis-care New York State Department of Health Hepatitis C Dashboard: https://hcvdashboardny.org/ New York State Department of Health, Frequently Asked Questions for Hepatitis C Point of Care Diagnostic Testing (June 2025): https://www.health.ny.gov/diseases/communicable/hepatitis/hepatitis_c/providers/docs/poc_faq.pdf Erie County Medical Center's Center for Hepatology Care (La Bodega): https://medicine.buffalo.edu/news_and_events/news/2020/04/martinez-bodega-hepatology-clinic-10699.html U.S. Food and Drug Administration News Release, FDA Permits Marketing of First Point-of-Care Hepatitis C RNA Test (June 2024): https://www.fda.gov/news-events/press-announcements/fda-permits-marketing-first-point-care-hepatitis-c-rna-test MacIsaac MB, et al. Point-of-care HCV RNA testing improves hepatitis C testing rates and allows rapid treatment initiation among people who inject drugs attending a medically supervised injecting facility. Int J Drug Policy. 2024 March:125:104317. doi:10.1016/j.drugpo.2024.104317. Point-of-care HCV RNA testing how to video: https://vimeo.com/1172653335?fl=ip&fe=ec

Episode 223: Oncogenic Viruses Introduction Mehr: Hi everyone, welcome back to the Rio Bravo qweek podcast. Back by popular demand is Me, Mehr Boparai a third-year medical student at COMP-NW. Here with me is Jeremy Pan from COMP who is also a third-year medical student. How are you doing Jeremy? Jeremy: I'm doing great Mehr.Thanks for the kind intro; we had a fun time this morning doing street medicine and had some practice giving Toradol injections and wound dressings. So excited to be back for another podcast episode this afternoon! Mehr: This week, we are moving away from bacteria and antibiotics and diving deeper into cancer-causing viruses. Jeremy: Yes, and if you are interested at all in public health, this is one of those areas where medicine overlaps with public health in a really tangible way. I think one of the most underappreciated aspects of this topic is that we have vaccines that can prevent many of these cancers. If you told someone 50 years ago we'd be vaccinating against cancer, they probably wouldn't believe you! It's amazing to see how far medicine has come. How viruses cause cancer: Jeremy: Before jumping into specific viruses, I always think having a mechanism-based framework makes everything stick better. Mehr: Right, because they don't all cause cancer the same way. Medicine can never be easy huh? Jeremy: Yea…this career really is just a lifetime of discovery. So just to start, in broad terms, we can think of three main buckets of how viruses can cause cancer: Direct oncogenesis where viral proteins interfere with tumor suppressors like P53 and Rb. We will go over their specific mechanisms a little later in the discussion. Mehr:  Chronic inflammation where viruses cause repeated injury through production of reactive oxygen species. They also increase the chance of mutation through repeated DNA replication, leading to cancer.  Jeremy: Immune evasion or suppression leads to decreased tumor surveillance. What this means essentially is that our immune system is constantly removing abnormal cells before they become cancerous. This is completed by CD8 T cells and natural killer, or NK, cells. CD8 T cells recognize abnormal peptides presented on Major Histocompatibility Complex, or MHC, class I molecules and induce apoptosis in those cells. Mehr: And NK cells step in when cells decide to stop expressing MHC I, which abnormal cells like to hide to avoid being caught. So just to reiterate, there are two layers to dissect here: if a cell looks suspicious with an abnormal MHC, CD8 T-cells kill them. If the abnormal cell decides to hide its MHC, then the NK cell will kill it instead. Jeremy: So, for the final big picture, we can think of oncogenic viruses as either disabling tumor suppression, causing chronic damage over time through inflammation, and weakening the immune system's ability to catch cancer in time before it develops. HPV Mehr: Let's start with one of the most common viruses afflicting our population – Human Papilloma Virus otherwise known as HPV.  Jeremy: Right, this notorious virus is probably the most clinically impactful oncogenic virus. The key players HPV utilizes are proteins E6 and E7. Mehr: Right! E6 binds to and inhibits p53, which normally acts to induce cell cycle arrest, and E7 inhibits Rb, which normally acts as a tumor suppressor gene that inhibits the G1 to S phase transition in a normal cell cycle. Jeremy: So essentially, we are losing both apoptosis and losing cell cycle control at the same time. What is interesting about HPV is that persistent infection, not just exposure to the virus, is what drives cancer risk.  Mehr: Exactly, most HPV infections clear on their own, but the ones that persist are the problem. Clinically, many end up being asymptomatic. However, for high-risk infections, we can see genital warts that can itch, feel tender, or cause abnormal vaginal bleeding and discharge. Patients are sometimes not able to have a vaginal delivery because of the warts that are present along their genital tract. We can also see warts on the hands and fingers or plantar surface of our feet. Jeremy: Another interesting point is that we are also seeing a shift where there are more cases of oropharyngeal cancers in younger, non-smoking patients. This is why if we see an abnormal neck lymph node or persistent sore throat after swallowing in a young patient, HPV should definitely be on the differential.  Mehr: Screening is very important as well! We typically discover high-risk HPV infections through routine Pap smears and other HPV specific tests through DNA PCR and RNA tests. We also encourage vaccination for effective prevention of both genital warts and high-risk HPV-related cancers. There was also a study in Scotland where there were zero cases of HPV in adults who received the vaccine between 12-13 years of age! Which is crazy!  EBV HBV & HCV Mehr: Now let's shift to viruses that affect the liver, Hepatitis B virus and Hepatitis C virus. Jeremy: Both are strongly associated with hepatocellular carcinoma, but they actually get there in slightlydifferent ways. Mehr: Right. Hepatitis B is a DNA virus that can integrate directly into the host genome, which can disrupttumor suppressor genes and promote oncogenesis. Jeremy: Whereas Hepatitis C is an RNA virus, so it doesn't integrate into the host genome. Instead, it causes chronic inflammation Over time, that leads to repeated cycles of hepatocyte injury and regeneration, along withoxidative stress from reactive oxygen species, which increases the risk of DNA mutations. Mehr: One really important clinical pearl is that Hep B can actually cause hepatocellular carcinoma evenwithout cirrhosis. Whereas with Hep C, the pathway is usually chronic inflammation → fibrosis → cirrhosis → dysplasia→ cancer.  Jeremy: So, screening becomes really important for both of these viruses. For high-risk patients—like those with chronic hepatitis or cirrhosis—we typically dosurveillance with liver ultrasound every 6 months, sometimes with alpha-fetoprotein levels to see if it is elevated. Mehr: From a prevention standpoint, the Hep B vaccine is a huge win. It significantly reduces the risk ofhepatocellular carcinoma. For Hep C, we don't have a vaccine, but direct-acting antivirals can actually cure the infection andreduce long-term cancer risk, which is why we screen between ages 18-79  nowadays. Global Hep B and C account for 65% of all HCC cases! So, it makes sense that primary care itself is increasing the treatment of Hep C cases as well since it is easier to prescribe and that you want to be treated ASAP.  Jeremy: Yea, the ability to treat Hep C is so beneficial to population health. Now let's say you have a patient who develops hepatocellular carcinoma, options can include surgicalresection, liver transplantation, local therapies, or systemic treatments depending on stage.  Even without trying, every night you go to bed a little wiser. Thanks for listening to Rio Bravo qWeek Podcast. We want to hear from you, send us an email at RioBravoqWeek@clinicasierravista.org, or visit our website riobravofmrp.org/qweek. See you next week!  __________________________________ References: Barry H. C. (2024). Scottish Screening: No Cases of Invasive Cervical Cancer in Women Who Received at Least One Dose of Bivalent HPV Vaccine at 12 or 13 Years of Age. American family physician, 110(2), 201–202. https://pubmed.ncbi.nlm.nih.gov/39172683/ Theme song, Works All The Time by Dominik Schwarzer, YouTube ID: CUBDNERZU8HXUHBS, purchased from https://www.premiumbeat.com/. Even without trying, every night you go to bed a little wiser. Thanks for listening to Rio Bravo qWeek Podcast. We want to hear from you, send us an email at RioBravoqWeek@clinicasierravista.org, or visit our website riobravofmrp.org/qweek. See you next week!

One of the most common arguments you hear from company executives racing to develop super-intelligent AI is that it will cure cancer. It's an incredibly powerful and seductive promise.  If superintelligent AI really can cure cancer, then anyone who stands in the way of it, anyone who wants to slow it down — even because of its serious risks — is essentially letting people die. In fact, the biggest risk would be going too slowly. But what if a superintelligent AI isn't actually capable of solving cancer in the way it's been described? What if we're being sold a false promise to justify a dangerous race? That's exactly what our guest this week argues is happening. Dr. Emilia Javorsky is a physician, public health researcher, and director of the Futures Program at the Future of Life Institute. She's worked across scientific research, clinical trials, tech startups, and AI policy.   Emilia recently wrote a paper titled “How AI Can and Can't Cure Cancer,” in which she argues that the promise of superintelligence curing cancer falls apart under scrutiny.  Emilia lost a parent to cancer, so her criticism of this promise comes from a place of real concern, not cynicism. It also comes from her belief that AI can be really revolutionary for medicine, if we build it the right way. Your Undivided Attention is produced by the Center for Humane Technology. Follow us on X: @HumaneTech_ and subscribe to our Substack.RECOMMENDED MEDIA How AI Can and Can't Cure Cancer by Emilia JavorskyThe Emperor of All Maladies by Siddhartha Mukherjee RECOMMENDED YUA EPISODES Decoding Our DNA: How AI Supercharges Medical Breakthroughs and Biological Threats with Kevin Esvelt Forever Chemicals, Forever Consequences: What PFAS Teaches Us About AI Big Food, Big Tech and Big AI with Michael MossCLARIFICATIONS: Emilia's claim that “the doubling rate of medical knowledge has gone from 50 years in the 1950s down to 73 days” comes from an oft-cited 2011 paper from the NIH. However, this paper does not include any methodology for arriving at this claim. Emilia stated that we have yet to cure any complex, chronic disease in humans. However, we have been able to cure Hepatitis C, which is considered a complex infectious disease, and we have managed to effectively cure some types of Leukemia Correction: Tristan incorrectly paraphrased a quote from Charlie Munger about incentives. The actual quote is “The basic rule of incentives is you get what you were owed for. So if you have a dumb incentive system, you get dumb outcomes."     Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

PODCAST LAS NOTICIAS CON CALLE DE 23 DE ABRIL DE 2026 - Conflicto de Irán aprieta, USA obliga a 31 barcos a virar - Fox News 6 meses cogería limpiar el estrecho de Hormuz de minas y otras - Fox NewsRivera Schatz versus jefe de la policía y federal en destaque por sargento ascendido - El Nuevo Día  Dos iglesias en fuego en Adjuntas, iglesia Manatial de Vida y luego en Parroquia San Joaquín - Policía Israel y Líbano se atacan mutuamente - Semafor Senado jura que no persigue a Sagardía, que no quiere sus planillas, sino las informativas - El Nuevo Día Confirman han aumentado los abortos en PR desde que se revocó el caso de Roe v. Wade - WSKN Alcalde de San Juan suelta contra La Junta de Planificación y advierte de reforma de permisos - El Nuevo Día  Péptidos son lo nuevo en el mundo de la medicina y wellness - Axios Molesta JGo porque debaten en Legislatura el presupuesto sin tener un proyecto de ella, pero dice que su proyecto espera por junta y reforma contributiva - El Vocero Cerrados portones UPR mientras se reúnen y piden renuncia de presidencia o se van a huelga - El Vocero First Medical en problemas otra vez, médicos y proveedores advierten de años de impagos - Metro Adelantan juicio contra CDobleta por asesinato de policía - El Vocero Policía tendría 800 agentes menos para el 2027 - El Vocero Casos de Hepatitis C en la cárcel siguen fuera de control pero solo 2% de la población ha sido evaluada - Metro Irán cierra Hormuz, EEUU intercepta dos supertanqueros iraníes Hegseth bota al Secretario de la Marina, John Phelan Tesla promete gastar $25,000 millones en IA y robótica este año.  LOS DATOS DEL DÍABrent: $101.91/barril (+3.30%) — futuros al día de hoy en $104.02Diésel wholesale (EEUU): $3.93/galónS&P 500: 7,137.90 (+1.05%) — récordDow Jones: 49,490.03 (+0.69%) — récordBono 10Y del Tesoro: 4.32%Euro/USD: 1.1733Gas natural (Henry Hub): $2.70/MMBtuTasa hipotecaria 30Y: 6.22%#universalinsurance #incluyeauspicio 

Sheinbaum confirma saldo blanco tras incendio en Dos BocasSalud recomienda prueba de Hepatitis C a mayores de 18 añosCuba acusa a EU de presionar contra cooperación médicaMás información en nuestro Podcast#grc

A new, rapid Hepatitis C test developed by Northwestern University scientists could change the future of Hepatitis C care by delivering faster diagnosis and treatments for a disease that is estimated to impact 50 million people around the world. The research behind this new test, which was built on the DASH (Diagnostic Analyzer for Specific Hybridization) Rapid PCR system developed at Northwestern University was published in the Journal of Infectious Diseases. In this episode, Claudia Hawkins, MD, MPH, explains this study and the impact this test could have on the global effort to eliminate Hepatitis C. 

Interview with Jocelyn Young, DO

There are fears reluctance about a new needle exchange service in the South Island may cause a rise in Hepatitis C and HIV cases. Rachel Graham reports.

This Week speaks to members of Transfusion Positive, who were caught up in the Hepatitis C contamination crisis in the 1990s. We then hear from Cliona O'Farrelly, Professor for Comparative Immunology at Trinity College Dublin

Self-care podcast exploring Why The Healing Mentality Matters, Importance of Addressing Root Causes & Steps to Addressing Root Cause Healing with Autumn McLees. TOPICS:: ** Why The Healing Mentality Matters (09:57). ** Importance of Addressing Root Causes (18:42). ** Steps to Addressing Root Cause Healing (29:32).   NOTES:: Show notes: amberapproved.ca/podcast/649 Leave me a review at amberapproved.ca/review Email me at info@amberapproved.ca   Subscribe to newsletter: https://amber-romaniuk.mykajabi.com/newsletter-sign-up    SHOW LINKS: Click below to schedule a 30 minute Complimentary Body Freedom Consultation https://amberapproved.ca/body-freedom-consultation/  Take my free Emotional Eating Quiz here: http://amberapproved.ca/emotional-eating-quiz Listen to Episode 291 about what it's like to work with me here: http://amberapproved.ca/podcast/291/ Follow me on Instagram www.instagram.com/amberromaniuk Youtube Channel: https://www.youtube.com/@amberromaniuk/    ABOUT MY GUEST: Autumn McLees challenges the status quo, equipping women to explore holistic alternative paths to wellness. After overcoming a life-altering autoimmune disease naturally, she's now pioneering her way on an unbeaten path that few, if any, have attempted when battling Hepatitis C.   Autumn is fervently dedicated to challenging traditional practices in healthcare, the food industry, dentistry, childbirth, and beyond. Having witnessed the effectiveness of holistic health approaches, she actively promotes awareness and education in these areas.   Autumn spearheads a top-rated podcast, "Know Better | Do Better," dedicated to advocating for holistic health awareness. As a certified high-performance coach and multifaceted entrepreneur, Autumn has earned recognition through awards, TV and radio appearances, magazine features, news articles, and multiple certifications. For nearly 9 years, Autumn has been the driving force behind a multimillion dollar wellness enterprise, and she is celebrated as a top achiever in her field.   F️REEBIE Clean Swap Guide: https://bit.ly/44EGv6b    Website: https://www.autumnmclees.com/ ️"Know Better | Do Better" Podcast Facebook:  https://www.facebook.com/autumn.mclees TikTok: https://www.tiktok.com/@autumn.mclees?_t=8jGMp83lS5G&_r=1 Instagram: https://www.instagram.com/autumn.mclees?igsh=MzRlODBiNWFlZA== MY PARTNERS: HERBAL FACE FOOD Stubborn eczema, red spots, aging spots, or acne on your face, chest, arms, or back from hormones or hard water damage? I have something SO amazing for you. Our mineral-heavy water started impacting my skin the moment we moved, and I had never experienced eczema or skin issues in my life. Hard water can strip natural oils, disrupt the microbiome, and weaken the skin barrier — leaving you inflamed, reactive, and stuck in flare-ups. That's exactly what happened to my neck, and within almost two weeks of using Herbal Face Food, my eczema is almost gone. This stuff is legit — and I only share my favorite things that actually work. Their formulas are made with ultra-potent, organic, whole-plant botanicals rich in antioxidants, polyphenols, and phytonutrients that calm inflammation, rebuild the skin barrier, and fight visible signs of aging instead of masking symptoms. The Cure is their most targeted antioxidant treatment designed to visibly improve stubborn concerns like eczema, melasma, rosacea, scarring, sun damage, and deeper signs of aging. The Cream is a deeply hydrating, ultra-potent botanical moisturizer that firms, smooths, strengthens the skin barrier, and helps reduce fine lines and wrinkles. The Soap gently cleanses without stripping, using powerful plant concentrates to protect, nourish, and support healthy, youthful-looking skin on both the face and body. If your skin has been struggling from hormones, environmental stress, hard water damage, or premature aging, I'm sharing exactly what I'm using and why it's working. Shop through my link in the show notes or visit https://herbalfacefood.com/?ref=AMBER88 and use code AMBER88 at checkout for 30% off your entire order.   MY PARTNERS: DEEP MARINE COLLAGEN By calming the immune system and nourishing the tissues of your joints, skin, gut, hair follicles and nail beds DeepMarine Collagen works from the inside out to produce Pain-Free Joints, Glowing Skin, Thicker Hair, Stronger Nails and a Healthy Gut. Canadian Listeners Use AMBER20 to receive 20% off all regular priced items by visiting deepmarine.ca or click the link https://deepmarine.ca/discount/AMBER20 to have the discount automatically applied to your order. Free Single Serve Sachets with select purchases while supplies last.   USA Listeners You can find DeepMarine Collagen on Amazon.com. Discounts will automatically be applied to select purchases.

Send a textIn this episode Charles & Lyn share their feelings about the decision by the Australian Human Rights Commission's decision to deny an inquiry into how tens of thousands of Australians impacted by tainted blood transfusions and tainted blood treatments could end up being abandoned.  Show links. Former Labor Health minister Neal Blewett says evidence that he is bisexual or gay is “scuttlebutt”  https://static.wixstatic.com/media/ddd792_2e7e1e141f4e41549717a2e224bc3544~mv2.jpgStatement by Charles MacKenzie to Infected Blood Inquiry (final 5 pages feature my appeal on behalf of Australia to inquiry chair) https://www.infectedbloodinquiry.org.uk/sites/default/files/2021-12-16%20WS/2021-12-16%20WS/WITN3939001%20-%20Written%20statement%20of%20Charles%20Mackenzie%20-%2015%20May%202020.pdfTimeline of discrimination by tax payer funded Hepatitis C groups against tainted blood victims. https://ddd792de-b24d-47fe-8177-91b7438b0894.usrfiles.com/ugd/ddd792_4ac055e13e0e43df9787d08f8f345c8f.pdfPurchase a Make Accountability Happen Again cap here https://joinhighadventure.com.au/patriot-cap/Support the petition for a Royal Commission of inquiry into the Australian Red Cross/CSL Infected Blood Scandal here https://www.infectedbloodaustralia.com/registration

Pati Chapoy y Karina Velasco, hija de Raúl Velasco, protagonizan un insólito reencuentro para sostener una charla más que reveladora.Pati la conoce prácticamente desde que su madre Dorle Velasco la llevaba en el vientre y ella fue a vivir a casa de Raúl para estar al pendiente del parto debido a los constantes viajes del periodista y conductor.Así que de la mano de Pati, Karina aborda desde sus inicios como comunicadora, hasta su fallido matrimonio y por supuesto la irremediable muerte de su famoso padre, luego de haber logrado alargar su vida gracias a un trasplante de hígado a que lo obligó la Hepatitis C que contrajo en una trasfusión de sangre.¿Cómo resolvió semejante duelo? Al responder a la pregunta de Pati, Karina relata la odisea que emprendió desde entonces para reencontrar su camino, convirtiéndose en chef, meditadora, estudiosa de la sexualidad humana e incluso en "poliamorosa" y escritora.Una conversación que fluye con la confianza de quienes se saben no sólo cercanas, sino familia y que es digna de verse porque nada es lo que parece.

Feb. 9, 2026- We highlight what the state is doing, and could be doing, to realize its goal of eliminating hepatitis C transition by 2030. Our guests are Shirley Toro, president and CEO of the National Black Leadership Commission, and Michael Selick, director of Capacity and Community Mobilization at National Harm Reduction Coalition.

This two-part episode of Buffalo HealthCast explores Hepatitis C treatment in Buffalo and in global contexts. In part one, family nurse practitioner and recent MPH graduate Sean Owen talks with guest host Jennifer Foster of the Office of Global Health Initiatives about hepatitis c: what it is, how it's treated, barriers to care, and global efforts to eliminate the virus. Owen talks about his long-running work in Rochester specializing in drug user health, harm reduction, and treatment and prevention of hepatitis C and HIV, along with his recent MPH field training experiences addressing hepatitis C under the supervision of Dr. Anthony Martinez at his clinic La Bodega at the Erie County Medical Center.In part two of this episode, Sean Owen talks to Scott Springer, a physician assistant at La Bodega. Owen and Springer discuss La Bodega's unique model of treatment and holistic care, which has contributed to great success in treating and curing hepatitis C among western New York patients. They also explore reasons why hepatitis C elimination efforts are unique in different parts of the country and different parts of the world. Read (and watch) more about the work at La Bodega: https://medicine.buffalo.edu/news_and_events/news/2020/04/martinez-bodega-hepatology-clinic-10699.htmlhttps://www.cbsnews.com/news/elminate-hepatitis-c-clinic-treatment/Follow us!Official WebpageBuzzsproutSpotifyApple PodcastsYoutubeInstagramFacebookTwitter

Send us a textAs When Humanitarians Kill gathers momentum, Charles and Lyn uncover a disturbing truth: two official inquiries into Australia's tainted blood disaster, the 1991 HIV inquiry and the 2004 hepatitis C inquiry, were quietly derailed. In this episode, they reveal how a small number of well placed gatecrashers intervened, sabotaging accountability and denying victims justice.Show links ‘An alliance of bias timeline'of government funded Hepatitis C groups discriminating against infected blood victims: Before and during the Senate Affairs ReferencesCommittee into hepatitis C and blood supply in Australia 2004 https://ddd792de-b24d-47fe-8177-91b7438b0894.usrfiles.com/ugd/ddd792_4ac055e13e0e43df9787d08f8f345c8f.pdfInquiry crasher Stuart Loveday of Hepatitis NSW lecturing tainted blood victims. https://www.youtube.com/watch?v=DZbIu5Rh7zgProfessor Arthur Bloomhttps://www.bbc.com/news/uk-wales-686247981990 Australian Red Cross telling blood donors found to have the deadly virus hepatitis C that they my continue to donate blood for a process known as ‘plasma fractionation' which is how haemophilia treatments were made.  https://static.wixstatic.com/media/ddd792_6c6046b9c92240f2b3df0c08d4e3db91~mv2.jpgCharles MacKenzie's submission to the Senate inquiry into hepatitis C and the Australian blood supply that he forced in 2004https://www.infectedbloodaustralia.com/_files/ugd/efbdad_895236b193ec408791159e72c47fc122.pdfA former manager of the Hepatitis Council whistleblows about discrimination against tainted blood victims here https://www.infectedbloodaustralia.com/_files/ugd/efbdad_b647814ebfa54607a31265ff034aed61.pdfBe part of making justice happen and purchase a Make Accountability Happen Again cap here https://joinhighadventure.com.au/patriot-cap/Support a Royal Commission of inquiry into the Australian Red Cross/CSL Infected Blood Scandal here https://www.infectedbloodaustralia.com/registration

The Chancellor announced dozens of changes in the Budget that will affect the money in your pocket from wages and energy bills to savings. Many of them won't happen for some time - years in some cases - so we look at the more imminent tax changes. That will include the freezing of tax thresholds that will see higher taxes for many and changes to the Cash ISA limits.A "bewildering system" of benefits - that's how the author of a new report has described the plight of tens of thousands of unpaid carers who were thrown into debt because of the overpayment of Carer's Allowance. This week an independent review was published that's been a year in the making. It started because carers had been working but had unwittingly slipped over the amount they're able to earn before losing their Carer's Allowance - a payment they're entitled to if they care for someone for over 35 hours a week, leaving them in debt to the government. Paul Lewis interviews the author of the report Liz Sayce, who has told Money Box the government must implement her recommendations "at pace".And, the families of thousands of people who were infected with HIV and Hepatitis C by the NHS when it used contaminated blood in the 1970s and 80s will not have to pay tax on the compensation many of them are still waiting for. That commitment came from Rachel Reeves in the Budget, after Money Box reported on a campaign to ensure those relatives weren't subject to inheritance tax bills of tens of even hundreds of thousands of pounds.Presenter: Paul Lewis Reporters: Dan Whitworth and Jo Krasner Researcher: Eimear Devlin Editor: Jess Quayle Senior News Editor: Sara Wadeson(First broadcast 12pm Saturday 29th November 2025)

Major health organizations, including the CDC and ACOG, recommend universal Hepatitis C Virus (HCV) screening for all pregnant women during each pregnancy and at time of delivery. Ideally, pregnant women should be screened for hepatitis C virus infection at the first prenatal visit of each pregnancy. If the antibody screen result is positive, hepatitis C virus RNA polymerase chain reaction testing is done to confirm the diagnosis. The risk of perinatal transmission of HCV is up to 9%, with at least one-third of transmissions occurring antenatally. While antiviral therapy is recommended for Hepatitis B in pregnancy with a viral load greater than 200,000 international units/mL to decrease the risk of vertical transmission, the same is not the case for Hep C. According to the ACOG CPG #6 from September 2023, there are no standard treatment protocols for Hep C in pregnancy but a new publication from the PINK journal (7 Dec 2025) is calling for a change. That new publication is, “Hepatitis C Treatment During Pregnancy: Time for a Practice Change”. Listen in for details. 1. ACOG CPG #6; Sept 20262. Bhattacharya D, Aronsohn A, Price J, Lo Re V. Hepatitis C Guidance 2023 Update: AASLD-IDSA Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America. 2023;:ciad319. doi:10.1093/cid/ciad319.3. Chappell CA, Kiser JJ, Brooks KM, et al. Sofosbuvir/¬Velpatasvir Pharmacokinetics, Safety, and Efficacy in Pregnant People With Hepatitis C Virus. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 2025;80(4):744-751. doi:10.1093/cid/ciae595.4. Reau N, Munoz SJ, Schiano T. Liver Disease During Pregnancy. The American Journal of Gastroenterology. 2022;117(10S):44-52. doi:10.14309/ajg.0000000000001960.5. Dutra, Karley et al. Hepatitis C Treatment During Pregnancy: Time for a Practice Change. American Journal of Obstetrics & Gynecology MFM, Volume 0, Issue 0, 1018656. Society for Maternal-Fetal Medicine Consult Series #56: Hepatitis C in Pregnancy-Updated Guidelines: Replaces Consult Number 43, November 2017. Society for Maternal-Fetal Medicine (SMFM). Electronic address: pubs@smfm.org, Dotters-Katz SK, Kuller JA, Hughes BL. American Journal of Obstetrics and Gynecology. 2021;225(3):B8-B18. doi:10.1016/j.ajog.2021.06.008

This week, Marianna sits down with Carolyn Chu and Astha Kanani from the National Clinician Consultation Center (NCCC) to talk about treatment interruptions when it comes to HIV and Hepatitis C or HCV. Learn about why this can happen, the impact on treatment outcomes, and what you as an HIV care provider can do to prevent them. -- Reach out to the NCCC at 844-ASK-NCCC or 844-275-6222. Learn more at nccc.ucsf.edu. Resources mentioned in this episode: Dannenberg C, Matthews H, Hüfner A, et al.  Long-term real-world use of cabotegravir/rilpivirine: adherence and virological efficacy over a 44-month observation period.  Infect Dis Ther.  2025:14(8):1775-1797.De La Hoz A, Pooja A, Kancharla A, et al.  Characteristics and outcomes of direct-acting antiviral experienced patients with hepatitis C undergoing retreatment at an essential hospital in the United States.  Open Forum Infect Dis.  2024;11(12):ofae704.-- Help us track the number of listeners our episode gets by filling out this brief form! (https://www.e2NECA.org/?r=AQX7941)--Want to chat? Email us at podcast@necaaetc.org with comments or ideas for new episodes. --Check out our free online courses: www.necaaetc.org/rise-courses--Download our HIV mobile apps:Google Play Store: https://play.google.com/store/apps/developer?id=John+Faragon&hl=en_US&gl=USApple App Store: https://apps.apple.com/us/developer/virologyed-consultants-llc/id1216837691

'Buenos días, Javi y Mar' informa que este jueves 30 de octubre se debate la obesidad en las Islas Canarias, con un 23% de adultos y un 35% de niños afectados, y el gobierno solicita declararla enfermedad crónica. También se analizan los precios de los alimentos en octubre, con una subida del IPC al 3% y el precio de una docena de huevos a 3,14€. Se comenta la fuerte lluvia en Sevilla y Huelva, con 100 litros por metro cuadrado en Sevilla. La noticia de unos monos escapados en Mississippi, infectados con Hepatitis C y COVID-19, causa preocupación. Se destaca la canción "Todo Contigo" de Álvaro de Luna. En CADENA 100, se debate que las personas que agradecen con la mano a los conductores son más positivas, empáticas y pacientes, y se clasifican los tipos de peatones. Se escucha "Moves Like Jagger" de Maroon 5 ft. Christina Aguilera. Se mencionan las calorías que se queman viendo películas de miedo. Pink interpreta "Just Like a Pill". En 'Buenos días, Javi y Mar', se habla sobre la ...

Hurricane Melissa makes second landfall in Cuba after lashing Jamaica with catastrophic flooding, brutal winds. Governor Newsom sues Trump Administration for illegally withholding SNAP food benefits. Chad Scary Movie Countdown #3. Turkey to discipline referees after uncovering mass betting scandal. New details revealed in NBA betting scandal. One-Hit Wonder Wednesday. Texas attorney general sues Tylenol company over autism claims. Lab monkeys infected with herpes and Hepatitis C escape following truck crash. Toronto outlasts Dodgers to even World Series. 

On today's episode of the MY House Podcast Isaac talks with Dr. Kira England from the Alaska Department of Health! Isaac and Dr. England talk about risk factors for the Hepatitis C Virus, pathways to treatment and the community's role in helping combat the spread of Hepatitis C among vulnerable populations.

On September 9th, CEI hosted its first in-person conference dedicated to hepatitis C and drug user health. A group of New York State-based clinicians met in Catskill for a full day agenda focused on (1) integrating wellness into clinical practice as a way to improve patient care and outcomes, and (2) innovative decision- making frameworks to help clinicians navigate complex scenarios in the absence of strong formal evidence, like clinical guidelines and peer reviewed studies. This episode of “Conversations with CEI” features conference planner and facilitator Taylor Edelmann – an educator and consultant working at the intersection of LGBTQIA+ health, drug user health and harm reduction – sharing his experience and insights about the day. Taylor currently oversees the Lighthouse Learning Collective at the National Harm Reduction Coalition, a program focused on supporting LGBTQIA+ harm reductionists and people who use drugs and engage in sex work. As one of the first openly transgender NCAA athletes, Taylor brings a deeply personal lens to his work advocating for gender-affirming care. He regularly provides clinical education and technical assistance to providers across the country, including Yale University and one of Connecticut's largest federally qualified health centers, and recently presented at the 2025 Harm Reduction International Conference in Bogotá, Colombia. Taylor is also the co- creator of ChemSex Awareness Week, and the lead author of Gender Affirming Harm Reduction: A Toolkit for Syringe Service Programs, the first resource of its kind developed specifically for social service providers in harm reduction settings.  Related Content:  2025 Annual NYS Hepatitis C and Drug User Health conference website: https://ceitraining.org/conference/conferences/3 Lighthouse Learning Collective at the National Harm Reduction Coalition: https://harmreduction.org/our-work/action/lighthouse-learning-collective/ Gender Affirming Harm Reduction: A Toolkit for Syringe Service Programs: https://lighthousetoolkit.my.canva.site/ Narrative Medicine: https://www.aamc.org/news/narrative-medicine-every-patient-has-story Drug, Set, and Setting: The Basis for Controlled Intoxicant Use: https://southwestrecoveryalliance.org/wp-content/uploads/2020/02/Drug-Set-and-Setting-Zinberg-N-1.pdf CEI Clinical Consultation Line 1-866-637-2342 A toll-free service for NYS clinicians offering real-time clinical consultations with specialists on HIV, sexual health, hepatitis C, and drug user health. ceitraining.org

About this Episode Episode 49 of “The 2 View” – New IDSA Complicated UTI Guidelines, Pediatric Nicotine OD, Hepatitis C Screening in the ED, High-Risk Delta Troponins Segment 1A – Pediatric Nicotine Ingestion Madelyn O, Hays HL, Kistamgari S, et al. Nicotine Ingestions Among Young Children: 2010–2023. Pediatrics. 2025;156(2):e2024070522. doi:10.1542/peds.2024-070522. Segment 1B – Finger Thoracostomy and Traumatic Pneumothorax/Hemothorax Blank, J, de Moya MA. Traumatic pneumothorax and hemothorax: What you need to know. J Trauma Acute Care Surg. Published online July 3, 2025. doi:10.1097/TA.0000000000004692 Beyer CA, Ruf AC, Alshawi AB, Cannon JW. Management of traumatic pneumothorax and hemothorax. Curr Probl Surg. 2025;63. doi:10.1016/j.cpsurg.2024.101707. Weingart, S. EMCrit 62 – Needle vs. Knife II: Needle Thoracostomy (Decompression)? EMCrit. Published online December 11, 2011. https://emcrit.org/emcrit/needle-finger-thoracostomy/ Lange C, Sharma M. Podcast #223 - ATLS Episode 4: Thoracic Trauma (Chapter 4). Total EM. October 27, 2020. https://www.totalem.org/emergency-professionals/podcast-223-atls-episode-4-thoracic-trauma-chapter-4 Segment 2A – Hepatitis C Screening in EDs Haukoos J, Rothman RE, Galbraith JW, et al. Hepatitis C Screening in Emergency Departments: The DETECT Hep C Randomized Clinical Trial. JAMA. 2025;334(6):497–507. doi:10.1001/jama.2025.10563 Segment 2B – Serial HS-Troponin Patterns Huggins C, Saltarell Ni, Swoboda TK, et al. Kinetic changes in high-sensitivity cardiac troponin for risk stratification of emergency department chest pain patients. Am J Emerg Med. 2025;93:176-181. doi:10.1016/j.ajem.2025.04.010. Segment 3 - Updated IDSA Guidelines on Complicated Urinary Tract Infections Splete H. IDSA Updates Guidelines on Complicated UTIS. Medscape. Published online July 18, 2025. https://www.medscape.com/viewarticle/idsa-updates-guidelines-complicated-utis-2025a1000j3l Trautner BW, Cortes-Penfield NW, Gupta K, et al. Complicated Urinary Tract Infections (cUTI): Clinical Guidelines for Treatment and Management. IDSA. Published online July 17, 2025. https://www.idsociety.org/practice-guideline/complicated-urinary-tract-infections/ Roberts M, Sharma M. 34 - Pertussis, Computer Interpretation of EKGs, Tuberculosis, Fluoroquinolone Side Effects. The 2 View. Published online April 10, 2024. https://2view.fireside.fm/34 Roberts M, Sharma M. 46 - Heat Stroke Tx, A New Virus, Oral Cephalosporins Vs Pyelo, Safe Discharges. The 2 View. Published online June 11, 2025. https://2view.fireside.fm/46 Bonus Reference – Ponytail Headache Blau JN. Ponytail Headache: A Pure Extracranial Headache. Headache. 2004;44(5):411-413. doi: 10.1111/j.1526-4610.2004.04092.x. Recurring Sources Center for Medical Education. http://ccme.org The Proceduralist. http://www.theproceduralist.org The Procedural Pause. https://journals.lww.com/em-news/blog/theproceduralpause/pages/default.aspx The Skeptics Guide to Emergency Medicine. http://www.thesgem.com Be sure to keep tuning in for more great prizes and fun trivia questions! Once you hear the question, please email us your guesses at 2viewcast@gmail.com and tell us who you want to give a shout-out to.

Dr. Morse Q&A - Polycystic Ovaries - Urethral Polyp - Hepatitis C - Boils - Cysts #791 00:00:00 - Intro - New Alcohol-Free Tinctures 00:03:58 - Hypothyroidism - Low Libido - Polycystic Ovaries - Urethral Polyp -Hepatitis C 00:37:20 - Fruitarian OMAD - Fasting Diet 00:43:15 - Bladder Infection 00:53:04 - Body Pain - Hyperthyroidism 01:15:47 - Boils - Cysts 00:03:58 - Hypothyroidism - Low Libido - Polycystic Ovaries - Urethral Polyp -Hepatitis C - Hashimoto's  What should I take for hormonal balance and stress? 00:37:20 - Fruitarian OMAD - Fasting Diet Would it be possible to live on a One Meal A Day (OMAD) Fruitarian Diet with daily fasting, and still get enough nutrients to thrive through life? 00:43:15 - Bladder Infection I've had a chronic bladder infection for 7 months now. 00:53:04 - Body Pain - Hyperthyroidism I live in a chronic state of constant pain every single day. 01:15:47 - Boils - Cysts I've been dealing with boils and cysts for 6 years, mostly in the pubic area, sometimes the groin too.

In the heart of Old Town Winchester, the RISE (Resources. Inclusion. Support. Empowerment.) Community Center stands as a testament to the power of community, compassion, and resilience. Home to AIDS Response Effort (ARE), the organization has evolved over the past 35 years from a small group of volunteers supporting those affected by HIV/AIDS into a vibrant hub for HIV services, LGBTQ+ support, and community empowerment. In this conversation on The Valley Today with host Janet Michael, executive director Katie Vance shared the journey of the center's transformation, the challenges faced, and the profound impact it continues to have on the lives of local residents. The RISE Community Center's mission is multifaceted: it provides free and confidential HIV, STI, and Hepatitis C testing, case management, and a range of harm reduction services. Katie emphasized the importance of accessible testing, noting a recent uptick in positive cases since the pandemic and the center's ability to connect individuals to life-saving medications and support. “People can live long, healthy lives with the right resources,” she explained, dispelling persistent myths and highlighting the advances in HIV treatment. But the RISE Community Center is more than a healthcare provider—it's a safe haven and a gathering place. The center hosts a variety of support and affinity groups, from LGBTQ+ youth and seniors to hobby-based meetups like Stitch and Bitch. Its library, housed in a former bank vault, offers hundreds of books and resources for parents and individuals seeking understanding and affirmation. The center's gender-affirming closet, community garden, and volunteer-run programs further illustrate its commitment to holistic care. Katie and Janet discussed the ongoing need for volunteers and community advocacy, especially in the face of dwindling funding and persistent stigma. The center relies on donations and the dedication of its volunteers to keep its doors open and its programs running. Katie called on the community to not only support financially but also to challenge harmful language and myths, and to show up for LGBTQ+ neighbors. The conversation closed with a sobering reflection: without ARE and the RISE Community Center, many in Winchester would lose access to critical health services, support networks, and a sense of belonging. As Katie put it, “It's a human rights issue, not a political one.” The RISE Comunity Center's story is a powerful reminder that when a community comes together to care for its most vulnerable, everyone benefits—and hope truly rises.

LAS NOTICIAS CON CALLE DE 23 DE JULIO DE 2025 - Comienza proceso para sacar a LUMA, pero justo cuando sale que el contrato que firmó el gobierno con los dueños de Genera no cuadra - El Vocero Playas llenas de E Coli: Sixto Escobar en San Juan, Vacía Talega en Loíza, Lugana de Condado en San Juan, Tropical Beach en Naguabo No quieren sacar a la gente de Punta Santiago para traer un mega proyecto - El Vocero DACO demanda por enseres dañados, tanto Cámara y Senado se unen a demanda - El Vocero Aparece en aparente suicidio médico ginecólogo que iban a acusar por agresión sexual - Primera HoraQuitar el IVU a medicamentos over the counter quitaría 200 millones al gobierno y 18 a los municipios, evalúan medida - El Vocero Se dispara dramáticamente las apuestas en tragamonedas, suben 50 años para 362 millones total - El Vocero Llega casa Kikuet al aeropuerto SJU - El Nuevo Día Van a sus vistas para regularizar su vida en PR y terminan deportados - El Nuevo DíaNo va apoyo PPD a Constitucional de Status, alcaldes PPD dice que no se unen a eso - El Nuevo DíaOtro alcalde busca ama de llaves y no consigue personal - El Nuevo Día Turista se declara culpable de prender fuego en Cabo Rojo - Primera Hora Más casos de Hepatitis C en PR - Primera Hora Caso de Audrinix se le vira a Justicia tras video, pero fiscalía dice que falta info para poder saber lo que realmente pasó - Primera HoraTrump llega a acuerdo con Japón para tarifas de 15% incluyendo carros - Bloomberg Si estás cansado de pagar de más por servicios que no usas ni necesitas, eshora de cambiarte a Liberty.Los planes ilimitados multi-línea Liberty Mix te permiten escoger y pagar solo por lo quenecesita cada línea, con más data de alta velocidad y cero cargos escondidos.Estos planes han sido diseñados con flexibilidad en mente, ofreciéndote un servicio quese ajusta a tus necesidades, y también a tu bolsillo.Visita tu tienda Liberty más cercana hoy y escoge el plan que mejor se ajusta a ti.Liberty, contigo siempre.Incluye auspicio

Emblematic of capitalist corporations, investment bank Goldman Sachs asks a revealing question that shows the evils of capitalism: ‘Is curing patients a sustainable business model?' Nicole Roussell and Professor Richard Wolff discuss the unhealthy effects of the profit drive and huge profits in the pharmaceutical industry, using Hepatitis C treatments as an example, and how the math would work with industry profit no longer built in. Professor Richard Wolff is an author & co-founder of the organization Democracy at Work. You can find his work at rdwolff.com.Join the The Socialist Program community at https://www.patreon.com/TheSocialistProgram to get exclusive content and help keep this show on the air.

From the 2025 annual meeting of the American Society for Virology, Charlie Rice, 2020 Nobel Laureate in Physiology or Medicine, talks with Vincent and Kathy about his career and the scientific difficulties he and his laboratory encountered in their attempts to achieve replication of hepatitis C virus in cells in culture. Hosts: Vincent Racaniello and Kathy Spindler Guest: Charlie Rice Subscribe (free): Apple Podcasts, RSS, email Become a patron of TWiV! Links for this episode Support science education at MicrobeTV 2020 Nobel Prize (Nobel Prizes) Hepatitis C human challenge study (Lancet Gastro Hepatol) Rat hepacivirus mouse model for hepatitis C (Hepatol) Replication of hepatitis C virus in cells in culture (Science) Lessons from domestication of HCV (Curr Opin Virol) Intro music is by Ronald Jenkees Send your virology questions and comments to twiv@microbe.tv Content in this podcast should not be construed as medical advice.

Program notes:0:40 AHA risk calculator in various ethnicities1:40 Works well in all of them2:40 Women and ethnicities3:00 Hepatitis C screening in EDs4:01 Many ethnicities represented5:01 Identified as having the virus6:01 Once they tested only 24% were referred7:01 It was free testing7:40 Failing US children8:41 78% more likely to die in the US9:41 Some of these are preventable10:24 Life expectancy after the pandemic11:24 Remains almost a year deficit12:24 Deaths from overdose declining13:17 End

July 7, 2025 - We check in with Dr. Andrew Talal, a member of the state's Hepatitis C Elimination Task Force, who provides an update on New York's goal of eliminating the transmission of the virus by 2030. He discusses work being spearheaded by the University of Buffalo and recommendations for state policymakers.

New York Times best selling author Mark Ebner is an award winning investigative journalist who has covered all aspects of celebrity and crime culture for Spy, Rolling Stone, Maxim, Details, Los Angeles, Premiere, Salon, Spin, Radar, Angeleno, The Daily Beast.com, Gawker.com, BoingBoing.net and New Times among other national and international and internet publications. He has repeatedly positioned himself in harm's way, conducting dozens of investigations into such subjects as Scientology, Pit Bull fighting in South Central Los Angeles, the Ku Klux Klan in Texas, celebrity stalkers, drug dealers, missing porn stars, sports groupies, mobsters, college suicides and Hepatitis C in Hollywood.Ebner has produced for and/or appeared as a journalist-commentator on NBC, ABC, CBS, MSNBC, A&E, The BBC, Channel 4 (UK), National Public Radio, Court TV, Fox News, FX, VH-1 and E! Entertainment Television. He has been a featured guest on The Daily Show with Jon Stewart, The Today Show, The Early Show, Inside Edition, The Dylan Ratigan Show, Tough Crowd with Colin Quinn, Fox & Friends, Catherine Crier Live, and a host of other television and radio programs in the US, Canada, the United Kingdom and Asia.Hollywood, Interrupted: Insanity Chic in Babylon -- The Case Against Celebrityhttps://amzn.to/3ZuZgYrBecome a supporter of this podcast: https://www.spreaker.com/podcast/the-opperman-report--1198501/support.